WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF ...

WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023. Estimated FY 2023 revenues in excess of $1.3 million is a record ...

WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF ITS ...

Vancouver, British Columbia – March 31, 2021 – Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQX: CANSF) is pleased to announce that it ...

The interest on the Convertible Debentures will be payable semi-annually in arrears, beginning on December 31, 2023, and will be payable in cash ...

WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED ...

WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY.

WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED ...

Calgary, Alberta – September 12, 2023 – Willow Biosciences Inc.("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company ...

WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D ...

SUNNYVALE, California – September 6, 2023 – Willow Biosciences Inc.(“Willow“) (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company focused ...

WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH ...

Sunnyvale, California – November 7, 2024 – Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading ...

WILLOW BIOSCIENCES ANNOUNCES CLOSING OF PRIVATE ...

Calgary, Alberta – July 18, 2024 – Willow Biosciences Inc. ... The Offering was conducted by Independent Trading Group (ITG) Inc. (the “Agent“), ...

Willow Biosciences Announces Completion of its First Commercial ...

VANCOUVER, BC, March 31, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX: CANSF) is pleased to ...

WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT ...

WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTS ... Calgary, Alberta – February 20, ...

WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC ...

Calgary, Alberta – February 29, 2024 – Willow Biosciences Inc.("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF), a leading biotechnology company focused ...

Willow Biosciences Announces Cannabinoid Scale-up And ...

Calgary, Alberta – March 12, 2020 – Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW; OTCQB: CANSF), is pleased to announce that it has ...

WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF ...

WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCING ... CALGARY, AB, Oct. 10, 2023 /PRNewswire/ - Willow Biosciences ...

WILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS ...

Willow has successfully completed the Stage 1 toxicological assessment of its FutureGrown™ CBG product for oral product applications, an important milestone for ...

WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ...

On May 30, 2024, the Company announced a strategic partnership with Laurus Labs to develop new biobased routes for seven active pharmaceutical ...

WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH ...

WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS ...

Willow Bio Secures $1.3M R&D Deal to Target $1B Market with ...

WILLOW BIOSCIENCES ANNOUNCES NEW PARTNERSHIP WITH A GLOBAL INGREDIENT MANUFACTURER TO ADVANCE DEVELOPMENT OF A HIGH VALUE INGREDIENT FROM ITS ...

WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL ... - WLNS

Willow has completed its transition as a San Francisco Bay Area-based biotech company. It has consolidated its operations, transitioning to ...

WILLOW BIOSCIENCES ANNOUNCES EXERCISE OF OVER ...

WILLOW BIOSCIENCES ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION AND COMPLETION OF PREVIOUSLY ANNOUNCED BOUGHT DEAL OFFERING ... Vancouver, British ...

Willow Biosciences Inc: Official Announcements - Stock Market News

WILLOW ANNOUNCES A SECOND PROGRAM WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP AN ENZYME FOR MANUFACTURING A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT.